Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News RXi Pharmaceuticals Corp RXII

Healthcare Biotechnology
"RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs."

Recent & Breaking News (NDAQ:RXII)

Phio Pharmaceuticals Announces Compliance with Nasdaq Listing Requirements

PR Newswire February 10, 2020

Phio Pharmaceuticals Announces Closing of $1.74 Million Registered Direct Offering Priced At-the-Market

PR Newswire February 6, 2020

Phio Pharmaceuticals Announces $1.74 Million Registered Direct Offering Priced At-the-Market

PR Newswire February 5, 2020

Phio Pharmaceuticals Announces Reverse Stock Split

PR Newswire January 14, 2020

Phio Pharmaceuticals to Present at Biotech Showcase 2020

PR Newswire January 6, 2020

Phio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders

PR Newswire December 13, 2019

Phio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develop Self-Delivering RNAi Immunotherapies for Treating Solid Tumors

PR Newswire November 21, 2019

Phio Pharmaceuticals Announces Closing of Public Offering of Common Stock

PR Newswire November 20, 2019

Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock

PR Newswire November 18, 2019

Phio Pharmaceuticals Announces Proposed Public Offering of Common Stock

PR Newswire November 13, 2019

Phio Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

PR Newswire November 12, 2019

Phio Pharmaceuticals to Highlight Self-delivering RNAi Technology at SITC 2019

PR Newswire October 29, 2019

Phio Pharmaceuticals Announces Adjournment of 2019 Annual Meeting of Stockholders

PR Newswire October 11, 2019

Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy

PR Newswire September 9, 2019

Phio Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Healthcare Conference

PR Newswire September 3, 2019

Phio Pharmaceuticals and Helmholtz Zentrum München to Collaborate on Novel Targets for the Use of Self-Delivering RNAi In T Cell and NK Cell Adoptive Cell Therapy Therapeutics

PR Newswire August 15, 2019

Phio Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update

PR Newswire August 12, 2019

Phio Pharmaceuticals to Present at Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum

PR Newswire May 20, 2019

Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights

PR Newswire May 14, 2019

Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1

PR Newswire February 15, 2019